ChemBriefZealand Pharma, Generate Strike AI Obesity Drug Deal Worth Up to $1.2 Billion
Zealand Pharma and Generate Biomedicines have partnered on an AI-driven protein-based obesity treatment program worth up to $1.2 billion. Generate will lead research while Zealand oversees clinical de
reuters · 2026-10-13 13:42